This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Asia: Oligonucleotide & Peptide Therapeutics
24-26 Feb, 2027
Grand Nikko Tokyo DaibaTokyo

Dewey Sutton, PhD
AmbioPharm における Research and Development Supervisor
スピーカー

プロフィール

Dr. Dewey Sutton earned his Ph.D. in Chemistry from the University of Georgia in 2016. His primary research focus was design and synthesis of strained alkynes for copper-free click conjugations. He began his career at Ambiopharm in 2017 and joined the Research and Development team in 2018. He is now R&D Supervisor at AmbioPharm North Augusta site (US), where he is working together with the peptide synthesis team.

アジェンダセッション

  • Greener, Smarter Peptide Manufacturing: Advancing Sustainability and Quality

    12:00pm